Your browser doesn't support javascript.
loading
Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings.
Semengue, Ezechiel Ngoufack Jagni; Armenia, Daniele; Inzaule, Seth; Santoro, Maria Mercedes; Dambaya, Béatrice; Takou, Désiré; Teto, Georges; Nka, Alex Durand; Yagai, Bouba; Fabeni, Lavinia; Chenwi, Collins; Angong Beloumou, Grâce; Djupsa Ndjeyep, Sandrine Claire; Colizzi, Vittorio; Perno, Carlo-Federico; Ceccherini-Silberstein, Francesca; Fokam, Joseph.
Afiliación
  • Semengue ENJ; Virology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.
  • Armenia D; Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.
  • Inzaule S; Evangelical University of Cameroon, Bandjoun, Cameroon.
  • Santoro MM; Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.
  • Dambaya B; Saint Camillus International University of Health and Medical Sciences, Rome, Italy.
  • Takou D; Department of Global Health, Academic Medical Center of the University of Amsterdam and Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.
  • Teto G; Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.
  • Nka AD; Virology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.
  • Yagai B; Faculty of Sciences, University of Yaoundé I, Yaoundé, Cameroon.
  • Fabeni L; Virology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.
  • Chenwi C; Virology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.
  • Angong Beloumou G; Virology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.
  • Djupsa Ndjeyep SC; Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.
  • Colizzi V; Evangelical University of Cameroon, Bandjoun, Cameroon.
  • Perno CF; Virology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.
  • Ceccherini-Silberstein F; Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.
  • Fokam J; Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani" - IRCCS, Rome, Italy.
J Antimicrob Chemother ; 76(5): 1277-1285, 2021 04 13.
Article en En | MEDLINE | ID: mdl-33501504
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Inhibidores de Integrasa VIH / Integrasa de VIH Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: J Antimicrob Chemother Año: 2021 Tipo del documento: Article País de afiliación: Camerún Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Inhibidores de Integrasa VIH / Integrasa de VIH Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: J Antimicrob Chemother Año: 2021 Tipo del documento: Article País de afiliación: Camerún Pais de publicación: Reino Unido